Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Insmed Inc (INSM)
Insmed Inc (INSM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,884,133
  • Shares Outstanding, K 143,062
  • Annual Sales, $ 245,360 K
  • Annual Income, $ -481,530 K
  • 60-Month Beta 0.95
  • Price/Sales 12.48
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade INSM with:

Options Overview Details

View History
  • Implied Volatility 44.98% ( -31.39%)
  • Historical Volatility 36.26%
  • IV Percentile 35%
  • IV Rank 39.21%
  • IV High 76.37% on 02/22/24
  • IV Low 24.74% on 07/10/23
  • Put/Call Vol Ratio 2.33
  • Today's Volume 1,184
  • Volume Avg (30-Day) 419
  • Put/Call OI Ratio 2.56
  • Today's Open Interest 45,047
  • Open Int (30-Day) 46,009

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate -1.13
  • Number of Estimates 7
  • High Estimate -1.04
  • Low Estimate -1.28
  • Prior Year -1.20
  • Growth Rate Est. (year over year) +5.83%

Price Performance

See More
Period Period Low Period High Performance
1-Month
25.06 +8.86%
on 02/22/24
29.91 -8.79%
on 02/16/24
-0.96 (-3.40%)
since 01/23/24
3-Month
23.55 +15.84%
on 11/28/23
32.00 -14.75%
on 12/28/23
+3.55 (+14.96%)
since 11/22/23
52-Week
16.04 +70.07%
on 03/24/23
32.00 -14.75%
on 12/28/23
+6.91 (+33.92%)
since 02/23/23

Most Recent Stories

More News
Insmed: Q4 Earnings Snapshot

Insmed: Q4 Earnings Snapshot

INSM : 27.28 (+0.48%)
Insmed: Q3 Earnings Snapshot

Insmed: Q3 Earnings Snapshot

INSM : 27.28 (+0.48%)
Insmed to Host Third-Quarter 2023 Financial Results Conference Call on Thursday, October 26, 2023

/PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare...

INSM : 27.28 (+0.48%)
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

/PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare...

INSM : 27.28 (+0.48%)
Why Shares of Insmed Are Soaring This Week

The biotech company announced positive top-line trial results and received upgrades from analysts.

BAC : 33.92 (+0.92%)
INSM : 27.28 (+0.48%)
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

/PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare...

INSM : 27.28 (+0.48%)
Why Insmed Stock Is Soaring Today

Investors applauded the company's latest clinical results.

INSM : 27.28 (+0.48%)
The Five Biotech Stocks Every Investor Should Know About

Avalon GloboCare Corp., (NASDAQ: ALBT) a developer of innovative precision diagnostics and provider of clinical laboratory services just announced that the United States Patent and Trademark Office (USPTO)...

ALBT : 0.3939 (+3.74%)
INSM : 27.28 (+0.48%)
VIR : 11.53 (+11.94%)
CODX : 1.1300 (+0.89%)
ANTX : 3.09 (-6.65%)
A Potentially Revolutionary Tuberculosis Test Can Produce Results in 24 Hours

With a rising prevalence of chronic diseases, we’re starting to see higher demand for clinical lab services. That being said, it’s no surprise that, according to Market.Us, the global market for clinical...

INSM : 27.28 (+0.48%)
VIR : 11.53 (+11.94%)
CODX : 1.1300 (+0.89%)
ANTX : 3.09 (-6.65%)
ALBT : 0.3939 (+3.74%)
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

/PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare...

INSM : 27.28 (+0.48%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Insmed is a biopharmaceutical company engaged in the development and commercialization of ARIKAYCE, or liposomal amikacin for inhalation, for at least two identified orphan patient populations: patients with nontuberculous mycobacteria (NTM) lung infections and cystic fibrosis (CF) patients with Pseudomonas...

See More

Key Turning Points

3rd Resistance Point 28.68
2nd Resistance Point 28.18
1st Resistance Point 27.73
Last Price 27.28
1st Support Level 26.77
2nd Support Level 26.27
3rd Support Level 25.82

See More

52-Week High 32.00
Last Price 27.28
Fibonacci 61.8% 25.90
Fibonacci 50% 24.02
Fibonacci 38.2% 22.14
52-Week Low 16.04

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar